مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Verion

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

video

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

sound

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Persian Version

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

View:

832
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Download:

0
مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Cites:

Information Journal Paper

Title

EVALUATION OF PARENTERAL CIPROFLOXACIN UTILIZATION AND COST IN AFZALIPOUR HOSPITAL OF KERMAN IN 2016: A SHORT REPORT

Pages

  891-898

Abstract

 Background and Objectives: Drug UTILIZATION EVALUATION of antibiotics leads to identifying drug-related problems, preventing antibiotic resistance, and controling pharmacotherapy COSTs. The aim of the present study was to evaluate the use of parenteral CIPROFLOXACIN in an inpatient setting and COST of its inappropriate use. Materials and Methods: This cross-sectional study was conducted in Afzalipour teaching hospital in KERMAN from October 2016 to December 2016. The Anatomical Therapeutic Chemical classification system and the Defined Daily Dose were used and the DDD/100 bed-days was calculated. The COST of parenteral CIPROFLOXACIN use was also determined. Descriptive statistics and binary logistic regression were used for data analysis. Results: One hundred and twelve patients received parenteral CIPROFLOXACIN during the study period. The total COST of parenteral CIPROFLOXACIN use was 13381.94 dollars. The use of parenteral CIPROFLOXACIN in 34 (30.36%) patients was inappropriate and the COST of it was 2572.11 dollars. The dose of parenteral CIPROFLOXACIN was not adjusted in 29 (25.89%) patients with chronic kidney disease. The overall parenteral CIPROFLOXACIN UTILIZATION was 9.12 DDD/100 bed-days. The ratio of mean prescribed daily dose to Defined Daily Dose was 1.43.Conclusion: The total parenteral CIPROFLOXACIN use and also its COST were higher than other countries. So it is necessary to develop appropriative strategies to reduce its use.

Cites

  • No record.
  • References

  • No record.
  • Cite

    APA: Copy

    DABAGHZADEH, F., EBRAHIMI, J., & ARAB, N.. (2017). EVALUATION OF PARENTERAL CIPROFLOXACIN UTILIZATION AND COST IN AFZALIPOUR HOSPITAL OF KERMAN IN 2016: A SHORT REPORT. JOURNAL OF RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES AND HEALTH SERVICES, 16(9 ), 891-898. SID. https://sid.ir/paper/71048/en

    Vancouver: Copy

    DABAGHZADEH F., EBRAHIMI J., ARAB N.. EVALUATION OF PARENTERAL CIPROFLOXACIN UTILIZATION AND COST IN AFZALIPOUR HOSPITAL OF KERMAN IN 2016: A SHORT REPORT. JOURNAL OF RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES AND HEALTH SERVICES[Internet]. 2017;16(9 ):891-898. Available from: https://sid.ir/paper/71048/en

    IEEE: Copy

    F. DABAGHZADEH, J. EBRAHIMI, and N. ARAB, “EVALUATION OF PARENTERAL CIPROFLOXACIN UTILIZATION AND COST IN AFZALIPOUR HOSPITAL OF KERMAN IN 2016: A SHORT REPORT,” JOURNAL OF RAFSANJAN UNIVERSITY OF MEDICAL SCIENCES AND HEALTH SERVICES, vol. 16, no. 9 , pp. 891–898, 2017, [Online]. Available: https://sid.ir/paper/71048/en

    Related Journal Papers

    Related Seminar Papers

  • No record.
  • Related Plans

  • No record.
  • Recommended Workshops






    Move to top
    telegram sharing button
    whatsapp sharing button
    linkedin sharing button
    twitter sharing button
    email sharing button
    email sharing button
    email sharing button
    sharethis sharing button